Building the house of CARDS by phenotyping on the fly

Using clinical, pathophysiological and immunological phenotyping of ARDS to refine management of COVID-19 is urgently required to improve outcomes from refractory hypoxia https://bit.ly/2VvZe1p

Detalles Bibliográficos
Autor principal: Rajendram, Rajkumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450144/
https://www.ncbi.nlm.nih.gov/pubmed/32616600
http://dx.doi.org/10.1183/13993003.02429-2020
Descripción
Sumario:Using clinical, pathophysiological and immunological phenotyping of ARDS to refine management of COVID-19 is urgently required to improve outcomes from refractory hypoxia https://bit.ly/2VvZe1p

Ejemplares similares